Capecitabine versus Paclitaxel After CDK4/6 Inhibitor Progression in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study
卡培他滨对比紫杉醇治疗CDK4/6抑制剂治疗进展后激素受体阳性、HER2阴性转移性乳腺癌:一项真实世界研究
期刊:Breast Cancer-Targets and Therapy
影响因子:3.400
doi:10.2147/BCTT.S598598
Birsin, Zeliha; Güren, Ali Kaan; Aliyev, Vali; Guliyev, Murad; Jeral, Seda; Cebeci, Selin; Çerme, Emir; Günaltılı, Murat; Abbasov, Hamza; Çiçek, Ebru; Atak, Süheyla; Sarı, Murat; Demirci, Nebi Serkan; Alan, Özkan
CDK4
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌